Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 03 Feb 2026
FDA Accepts Resubmitted BLA for RelabotulinumtoxinA for Glabellar and Lateral Canthal Lines
Read Full NewsThe AAN's new guideline enhances diagnosis and management of functional seizures, emphasizing psychological interventions and addressing care gaps for better patient outcomes.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending January 30, 2026.
Mallon explains the shared risks linking celiac disease and type 1 diabetes and why early screening improves outcomes.
Nedelkopoulou emphasizes the importance of structured and multidisciplinary transition programs for young patients with IBD and HPB disease.
FDA Accepts Oxylanthanum Carbonate NDA Resubmission for Hyperphosphatemia in CKD, Dialysis
6 Nephrology Headlines You Missed In January 2026
OptIMMize-1: New Efficacy and Safety Data on Risankizumab in Pediatric Psoriasis
1.
For older patients with Hodgkin lymphoma, novel regimens produce high response rates.
2.
iPSC-based vaccines: A new hope for preventing and treating colorectal cancer
3.
La interacción GBP3-STING en el glioblastoma coordina la respuesta deficiente al temozolomide.
4.
In CML Patients With New Diagnoses, STAMP Inhibitor Outperforms Imatinib and Second-Gen TKIs.
5.
High levels of traumatic stress found in caregivers of adult cancer patients
1.
Innovative Bioengineering Approaches for Erectile Function Recovery After Radical Prostatectomy
2.
Antibody-Drug Conjugates in Oncology: Breakthroughs, Clinical Updates, and Pipeline Innovation
3.
AI in Cancer Care: Transforming Research & Treatment with Deep Learning Technologies
4.
Decoding Efficacy, Safety, and Future Frontiers in CAR-T Cell Therapy for Hematologic Malignancies Towards CAR-T Therapy 2025
5.
A Mural of Thrombus: Unlocking the Power of Art to Combat Cardiovascular Disease
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI
5.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge